Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

Clinical trial NCT04585958 · RECRUITING

Trial details

NCT number: NCT04585958
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Solid Neoplasm Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma Unresectable Malignant Solid Neoplasm

Start date: 2021-05-21
Primary completion: 2026-12-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.